Botulinum Toxin A for Emotional Stabilization in Borderline Personality Disorder (BPD)
Status:
Completed
Trial end date:
2019-10-31
Target enrollment:
Participant gender:
Summary
The main objective of the trial is to test whether a single application of botulinum toxin A
into the glabellar region will lead to emotional stabilization in borderline personality
disorder through paralysis of facial muscles/attenuation of negative emotions.
Phase:
Phase 2
Details
Lead Sponsor:
Hannover Medical School
Treatments:
abobotulinumtoxinA Botulinum Toxins Botulinum Toxins, Type A incobotulinumtoxinA onabotulinumtoxinA